Non-cancer effects after proton beam therapy for pediatric tumors- a narrative review
- PMID: 40519295
- PMCID: PMC12162316
- DOI: 10.3389/fonc.2025.1554765
Non-cancer effects after proton beam therapy for pediatric tumors- a narrative review
Abstract
Introduction: Radiation therapy can cause serious complications and side effects, especially in children. Proton beam therapy is considered as safer and more effective than traditional photon therapy because this type of modality offers precise radiation dose delivery to cancer cells while minimizing irradiation dose to adjacent normal tissue. Moreover, pediatric patients undergoing PBT may also experience a range of non-cancer late effects, including brainstem injury, cognitive dysfunctions, and side effects from endocrine or cardiovascular systems. The present type and frequency of non-cancer effects in children after proton therapy.
Methods: Therefore, this review aims to analyze publications addressing the occurrence of side effects from proton therapy in pediatric patients, excluding those related to the induction of secondary malignancies. We used data from two publicly available databases for this review: the U.S. National Library of Medicine's ClinicalTrials.gov (https://clinicaltrials.gov) for the analysis of clinical trials and PubMed, utilizing iCite (https://iCite.od.nih.gov)/Office of Portfolio Analysis, NIH, Bethesda, MD), a web-based application providing access to bibliometric information on publications.
Results: The review of the literature shows that PBT reduces the risk of cognitive, neuroendocrine, and cardiovascular dysfunctions concerning those observed after PT. Contradictory results were observed for brain stem injury. The majority of studies found cumulative incidence (CI) of brainstem injury at a relatively low level (0.7% - 5.0%) after PBT, as compared to PT.
Discussion: However, some authors underlie a higher rate of brainstem injury in children irradiated due to tumors localized in PF. Therefore, further studies, especially prospective ones, are needed to accurately describe the incidence and risk of late toxicity of proton beam therapy in children.
Keywords: late toxicity; non-cancer effects; pediatric tumors; photon therapy (PT); proton beam therapy (PBT).
Copyright © 2025 Zając-Grabiec, Biesaga, Krzyżowska, Drosik-Rutowicz and Miszczyk.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Brainstem Toxicity in Pediatric Patients Treated with Protons Using a Single-vault Synchrocyclotron System.Int J Part Ther. 2022 Jun 3;9(1):12-17. doi: 10.14338/IJPT-22-00008.1. eCollection 2022 Summer. Int J Part Ther. 2022. PMID: 35774490 Free PMC article.
-
Outcome after proton beam therapy versus photon-based radiation therapy in childhood-onset craniopharyngioma patients-results of KRANIOPHARYNGEOM 2007.Front Oncol. 2023 Oct 27;13:1180993. doi: 10.3389/fonc.2023.1180993. eCollection 2023. Front Oncol. 2023. PMID: 37965466 Free PMC article.
-
Quantifying the risk and dosimetric variables of symptomatic brainstem injury after proton beam radiation in pediatric brain tumors.Neuro Oncol. 2022 Sep 1;24(9):1571-1581. doi: 10.1093/neuonc/noac044. Neuro Oncol. 2022. PMID: 35157767 Free PMC article.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Risk of secondary malignant neoplasms in children following proton therapy vs. photon therapy for primary CNS tumors: A systematic review and meta-analysis.Front Oncol. 2022 Aug 12;12:893855. doi: 10.3389/fonc.2022.893855. eCollection 2022. Front Oncol. 2022. PMID: 36033525 Free PMC article.
References
-
- Mishra MV, Khairnar R, Bentzen SM, Larson G, Tsai H, Sinesi C, et al. Proton beam therapy delivered using pencil beam scanning vs. passive scattering/uniform scanning for localized prostate cancer: Comparative toxicity analysis of PCG 001-09. Clin Transl Radiat Oncol. (2019) 19:80–6. doi: 10.1016/j.ctro.2019.08.006 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources